Pay in 4 interest-free payments of $5.55 Learn more
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31
Use the dose volume provided for your current prescription
Food & Drug Administration (FDA) FDA grants accelerated approval to elamipretide (Forzinity) as first treatment for Barth syndrome (2025) Journal of the American College of Cardiology (JACC) PROGRESSHF trial: safety and tolerability of elamipretide in heart failure patients Neurology (AAN Journals) MMPOWER2 trial: elamipretide in primary mitochondrial myopathy Genetics in Medicine (Nature) TAZPOWER trial: efficacy and safety of elamipretide in Barth syndrome Biochimica et Biophysica Acta (BBA) Bioenergetics Cardiolipin remodeling and cristae structure: role in mitochondrial function Journal of Cardiovascular Pharmacology (PMC) SS31 reduces oxidative stress and improves mitochondrial bioenergetics Alzheimers Drug Discovery Foundation Cognitive Vitality Report: SS31 (elamipretide) preclinical and clinical overview Orphanet Journal of Rare Diseases (PMC) Barth syndrome: clinical presentation, diagnosis, and emerging therapies Research Resources BPC-157 (5 mg & 10 mg Vial) Dosage Protocol Quickstart Highlights BPC-157 (Body Protection Compound-157) is a synthetic 15-amino-acid peptide derived from a gastric protein sequence studied for tissue-healing and cytoprotective properties [1] [2]
Probiotics and Prebiotics to Improve Gut Health Your gut microbiome consists of millions of different bacteria
Even in the late 1990s, when I first began researching diet and disease for the journal Science , influential physicians told me that they advised patients to lower their cholesterol by diet, knowing that many to most would faileither because the diets were ineffective or unsustainable
2.4% with placebo [10]
Do not stop or change the dose without the prescriber unless emergency instructions tell you otherwise
